Skip to content
Checked.be
Complete company report
Generated 16-08-2026
Active BE 0892.121.272Private limited company

ODYSSEA PHARMA

Rue du Travail 16 ·4460 Grâce-Hollogne, Belgium· 18 yrs active
Sector: Vervaardiging van geneesmiddelen (21201)
Conclusion Checked

The computed 12-month bankruptcy probability of ODYSSEA PHARMA is 0.6% (low). The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 18 yrs
Board 5
Locations 1
Publications 18
Bankruptcy probability (12 mo) Checked model v1 · free
0.6% Low
0%0,5%1,5%4%10%≥25%
Long track record −Higher-failure-rate sector +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Established
Founded in 2007, 18 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (ander). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 ander 23-07-2025 2025-00297729
31-12-2023 ander 18-07-2024 2024-00267230
31-12-2022 ander 09-08-2023 2023-00324328
31-12-2021 ander 06-07-2022 2022-20155351
31-12-2020 ander 26-07-2021 2021-40000476
31-12-2019 volledig 31-07-2020 2020-39300196
31-12-2018 volledig 22-07-2019 2019-38100384
31-12-2017 volledig 27-07-2018 2018-42700049
31-12-2016 volledig 12-10-2017 2017-67200523
31-12-2015 volledig 05-07-2016 2016-28400327
Directors & mandates 34 directors
Current directors & mandates
  • David Brésart
    Director
    State Gazette act 25112150 (04-09-2025)
    Current
    04-09-2025 → present
  • Cécil Ruwet
    Mandataire spécial (gestion des ressources humaines)
    State Gazette act 21134296 (16-11-2021)
    Current
    16-11-2021 → present
  • Nadine Crocaerts
    Mandataire spécial (publication au moniteur belge)
    State Gazette act 21134296 (16-11-2021)
    Current
    16-11-2021 → present
  • Stephanie Struyfs
    Mandataire spécial (publication au moniteur belge)
    State Gazette act 21134296 (16-11-2021)
    Current
    16-11-2021 → present
  • Meike Elisabeth Celine Colette Kerstens
    Director
    State Gazette act 21019706 (12-02-2021)
    Current
    12-02-2021 → present
Historic, not recently confirmed (14)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Diego Gaspar
    Gérant
    State Gazette act 19023872 (15-02-2019)
    Not recently confirmed
    last confirmed in an act from 2019
  • Joachim Colot
    Gérant
    State Gazette act 19023872 (15-02-2019)
    Not recently confirmed
    last confirmed in an act from 2019
  • Maurice Mulders
    Gérant non statutaire
    State Gazette act 16142488 (14-10-2016)
    Not recently confirmed
    last confirmed in an act from 2016
  • Pascal Bertholete
    Daily management delegate
    State Gazette act 16142488 (14-10-2016)
    Not recently confirmed
    last confirmed in an act from 2016
  • Cécile RUWET
    Délégué à la gestion des ressources humaines
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
    2 events
    • 29-10-2015 Appointed· Délégué à la gestion des ressources humaines
    • 17-08-2015 Appointed· Délégué à la gestion des ressources humaines
  • Gudjon Gustafsson
    Délégué à la gestion bancaire
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Janine De Keersmaecker
    Mandataire (procuration spéciale)
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Jonathan Ventura
    Mandataire (procuration spéciale)
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Maria Teresa Hilad
    Délégué à la gestion bancaire
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Olivier Armand
    Mandataire (procuration spéciale)
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • Stephen Michael Kaufhold
    Délégué à la gestion bancaire
    State Gazette act 15152746 (29-10-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • SPRL BUILDING MANUFACTURING VALUELegal entity
    Daily management delegate
    State Gazette act 15118413 (17-08-2015)
    Not recently confirmed
    last confirmed in an act from 2015
  • SA UTERON PHARMALegal entity
    Managing director
    State Gazette act 11115364 (27-07-2011)
    Not recently confirmed
    last confirmed in an act from 2011
    2 events
    • 27-07-2011 Appointed· Managing director
    • 27-07-2011 Appointed· Daily management delegate
  • SPRL MAJOCEPILegal entity
    Director
    State Gazette act 11115364 (27-07-2011)
    Not recently confirmed
    last confirmed in an act from 2011
Permanent representatives (2)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
  • Thomas Meurice
    Représentant permanent
    State Gazette act 24177046 (17-12-2024)
    Permanent representative
    17-12-2024 → present
  • Mélanie Adorante
    Représentant permanent du commissaire
    State Gazette act 23067843 (24-05-2023)
    Permanent representative
    24-05-2023 → present
Former directors (15)
  • Kai Welzel
    Daily management delegate
    State Gazette act 24114818 (30-07-2024)
    Former
    30-07-2024 → 04-09-2025
    2 events
    • 04-09-2025 Resigned· Daily management delegate
    • 30-07-2024 Appointed· Daily management delegate
  • Lionel Rosoux
    Daily management delegate
    State Gazette act 21134296 (16-11-2021)
    Former
    16-11-2021 → 30-07-2024
    2 events
    • 30-07-2024 Resigned· Daily management delegate
    • 16-11-2021 Appointed· Daily management delegate
  • Meike Kerstens
    Director
    State Gazette act 24114818 (30-07-2024)
    Former
    - → 30-07-2024
  • Francisco Javier Aracil Corma
    Gérant
    State Gazette act 19104946 (01-08-2019)
    Former
    01-08-2019 → 12-02-2021
    2 events
    • 12-02-2021 Resigned· Director
    • 01-08-2019 Appointed· Gérant
  • Pascal Bertholet
    Gérant
    State Gazette act 19023872 (15-02-2019)
    Former
    - → 15-02-2019
10 further former directors in the mandate history. Available in Kantoor S. See plans →
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Statutory auditor 5 auditor
Statutory auditor IRE/IBR number Tenure
EY Réviseurs d'EntreprisesCurrent
Commissaire
 - 17-12-2024 → present
Show 4 earlier auditors
Mélanie Adorante
Commissaire aux comptes
succeeded by PwC Réviseurs d'Entreprises in 2023
 - 27-01-2021 → 24-05-2023
Peter D'Hondt
Commissaire
succeeded by Mélanie Adorante in 2021
 - 12-05-2017 → 27-01-2021
PwC Reviseurs d'Entreprises SRL
Commissaire
 - - → 17-12-2024
PwC Réviseurs d'Entreprises
Commissaire
succeeded by EY Réviseurs d'Entreprises in 2024
 - 24-05-2023 → 17-12-2024
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Vervaardiging van geneesmiddelen(21201)
Legal form Private limited company(610)
Incorporation18-09-2007
StatusActive
Postal code4460
Establishment units 1 location
ODYSSEA PHARMA
Rue du Travail 16, 4460 Grâce-HollogneProductie van edelmetalen
since 20072.165.409.984
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62046A0026/02_000 Wallonia 7,769 m² 1 · 2,744 m² 10.1 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 28 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025
04-09-2025
State Gazette act Director changes
v3.2
23-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · ander
2024
17-12-2024
State Gazette act Director changes
v3.2
30-07-2024
State Gazette act Director changes
v3.2
18-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · ander
30-01-2024
State Gazette act Director changes
v3.2
2023
09-08-2023
NBB filing Annual accounts filed
fiscal year 2022 · ander
24-05-2023
State Gazette act Director changes
v3.2
2022
06-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · ander
2021
16-11-2021
State Gazette act Director changes
v3.2
26-07-2021
NBB filing Annual accounts filed
fiscal year 2020 · ander
12-02-2021
State Gazette act Statutes amendment
v3.2
27-01-2021
State Gazette act Director changes
v3.2
2020
31-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2019
01-08-2019
State Gazette act Director changes
v3.2
22-07-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
15-02-2019
State Gazette act Director changes
v3.2
2018
27-07-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
28-05-2018
State Gazette act Director changes
v3.2
09-01-2018
State Gazette act Statutes amendment
v3.2
2017
12-10-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
12-05-2017
State Gazette act Director changes
v3.2
2016
14-10-2016
State Gazette act Director changes
v3.2
05-07-2016
NBB filing Annual accounts filed
fiscal year 2015 · volledig
2015
29-10-2015
State Gazette act Director changes
v3.2
21-08-2015
State Gazette act Director changes
v3.2
17-08-2015
State Gazette act Director changes
v3.2
2011
27-07-2011
State Gazette act Director changes
v3.2
Belgian State Gazette reading coverage 0 of 26 acts read

We know of 26 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 18 acts
All acts · 18 updated 11 months ago
2025
04-09-2025 1 director appointed, 1 resigning Director changes
  • David Brésart, Bestuurder
  • Kai Welzel, Dagelijks bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "David Br\u00E9sart",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Kai Welzel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "Odyssea Pharma"
  }
}
2024
17-12-2024 2 directors appointed, 1 resigning Director changes
  • EY Réviseurs d'Entreprises, Commissaire
  • Thomas Meurice, Représentant permanent
  • PwC Reviseurs d'Entreprises SRL, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PwC Reviseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent",
      "person": {
        "rrn": null,
        "name": "Thomas Meurice",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "Odyssea Pharma"
  }
}
30-07-2024 1 director appointed, 2 resigning Director changes
  • Kai Welzel, Dagelijks bestuur
  • Meike Kerstens, Bestuurder
  • Lionel Rosoux, Dagelijks bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Meike Kerstens",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Lionel Rosoux",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Kai Welzel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
30-01-2024 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "Odyssea Pharma"
  }
}
2023
24-05-2023 2 directors appointed Director changes
  • PwC Réviseurs d'Entreprises, Commissaire
  • Mélanie Adorante, Représentant permanent du commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PwC R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "Odyssea Pharma"
  }
}
2021
16-11-2021 4 directors appointed Director changes
  • Lionel Rosoux, Dagelijks bestuur
  • Cécil Ruwet, Mandataire spécial (gestion des ressources humaines)
  • Nadine Crocaerts, Mandataire spécial (publication au moniteur belge)
  • Stephanie Struyfs, Mandataire spécial (publication au moniteur belge)
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Lionel Rosoux",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "mandataire sp\u00E9cial (gestion des ressources humaines)",
      "person": {
        "rrn": null,
        "name": "C\u00E9cil Ruwet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "mandataire sp\u00E9cial (publication au Moniteur belge)",
      "person": {
        "rrn": null,
        "name": "Nadine Crocaerts",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "mandataire sp\u00E9cial (publication au Moniteur belge)",
      "person": {
        "rrn": null,
        "name": "Stephanie Struyfs",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
12-02-2021 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "Odyssea Pharma"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "changed": false
  }
}
27-01-2021 Mélanie Adorante appointed as commissaire aux comptes Director changes
  • Mélanie Adorante, Commissaire aux comptes
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire aux comptes",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
2019
01-08-2019 Francisco Javier Aracil Corma appointed as gérant Director changes
  • Francisco Javier Aracil Corma, Gérant
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "g\u00E9rant",
      "person": {
        "rrn": null,
        "name": "Francisco Javier Aracil Corma",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
15-02-2019 2 directors appointed, 1 resigning Director changes
  • Joachim Colot, Gérant
  • Diego Gaspar, Gérant
  • Pascal Bertholet, Gérant
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "g\u00E9rant",
      "person": {
        "rrn": null,
        "name": "Pascal Bertholet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "g\u00E9rant",
      "person": {
        "rrn": null,
        "name": "Joachim Colot",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "g\u00E9rant",
      "person": {
        "rrn": null,
        "name": "Diego Gaspar",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
2018
28-05-2018 Pat O'Donnell resigns as gerant non statutaire Director changes
  • Pat O'Donnell, Gerant non statutaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "gerant non-statutaire",
      "person": {
        "rrn": null,
        "name": "Pat O\u0027Donnell",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "DE LIE DIMSION LIEGE"
  }
}
09-01-2018 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  },
  "legal_form_change": {
    "new": "soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
    "old": "soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
    "changed": false
  }
}
2017
12-05-2017 Peter D'Hondt appointed as commissaire Director changes
  • Peter D'Hondt, Commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Peter D\u0027Hondt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
2016
14-10-2016 3 directors appointed, 3 resigning Director changes
  • Pat O'Donnell, Gérant non statutaire
  • Maurice Mulders, Gérant non statutaire
  • Pascal Bertholete, Dagelijks bestuur
  • Patrick Gerard Brunner, Gérant non statutaire
  • James Arthur Williamson, Gérant non statutaire
  • Christian CROMLIN, Dagelijks bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "g\u00E9rant non-statutaire",
      "person": {
        "rrn": null,
        "name": "Patrick Gerard Brunner",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "g\u00E9rant non-statutaire",
      "person": {
        "rrn": null,
        "name": "James Arthur Williamson",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "g\u00E9rant non-statutaire",
      "person": {
        "rrn": null,
        "name": "Pat O\u0027Donnell",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "g\u00E9rant non-statutaire",
      "person": {
        "rrn": null,
        "name": "Maurice Mulders",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Christian CROMLIN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Pascal Bertholete",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "Odyssea Pharma"
  }
}
2015
29-10-2015 8 directors appointed, 1 resigning Director changes
  • Christian CROMLIN, Dagelijks bestuur
  • Cécile RUWET, Délégué à la gestion des ressources humaines
  • Maria Teresa Hilad, Délégué à la gestion bancaire
  • Stephen Michael Kaufhold, Délégué à la gestion bancaire
  • Gudjon Gustafsson, Délégué à la gestion bancaire
  • Janine De Keersmaecker, Mandataire (procuration spéciale)
  • Olivier Armand, Mandataire (procuration spéciale)
  • Jonathan Ventura, Mandataire (procuration spéciale)
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Christian CROMLIN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Christian CROMLIN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion des ressources humaines",
      "person": {
        "rrn": null,
        "name": "C\u00E9cile RUWET",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion bancaire",
      "person": {
        "rrn": null,
        "name": "Maria Teresa Hilad",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion bancaire",
      "person": {
        "rrn": null,
        "name": "Stephen Michael Kaufhold",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion bancaire",
      "person": {
        "rrn": null,
        "name": "Gudjon Gustafsson",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "mandataire (procuration sp\u00E9ciale)",
      "person": {
        "rrn": null,
        "name": "Janine De Keersmaecker",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "mandataire (procuration sp\u00E9ciale)",
      "person": {
        "rrn": null,
        "name": "Olivier Armand",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "mandataire (procuration sp\u00E9ciale)",
      "person": {
        "rrn": null,
        "name": "Jonathan Ventura",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
21-08-2015 2 directors appointed, 1 resigning Director changes
  • James Arthur Williamson, Gérant
  • Patrick Gerard Brunner, Gérant
  • David Buchen, Gérant unique
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "g\u00E9rant unique",
      "person": {
        "rrn": null,
        "name": "David Buchen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "g\u00E9rant",
      "person": {
        "rrn": null,
        "name": "James Arthur Williamson",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "g\u00E9rant",
      "person": {
        "rrn": null,
        "name": "Patrick Gerard Brunner",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARM\u0410"
  }
}
17-08-2015 2 directors appointed, 1 resigning Director changes
  • SPRL BUILDING MANUFACTURING VALUE, Dagelijks bestuur
  • Mme Cécile RUWET, Délégué à la gestion des ressources humaines
  • SPRL SVR Invest, Dagelijks bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "SPRL SVR Invest",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "SPRL BUILDING MANUFACTURING VALUE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion des ressources humaines",
      "person": {
        "rrn": null,
        "name": "Mme C\u00E9cile RUWET",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
2011
27-07-2011 4 directors appointed, 6 resigning Director changes
  • SPRL SVR INVEST, Bestuurder
  • SA UTERON PHARMA, Gedelegeerd bestuurder
  • SPRL MAJOCEPI, Bestuurder
  • SA UTERON PHARMA, Dagelijks bestuur
  • François FORNIERI, Bestuurder
  • François FORNIERI, Président du conseil d'administration
  • SPRL YIMA, Bestuurder
  • SPRL YIMA, Gedelegeerd bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois FORNIERI",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "pr\u00E9sident du conseil d\u0027administration",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois FORNIERI",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "SPRL YIMA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "SPRL YIMA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "SA MITHRA PHARMACEUTICALS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "SPRL FAXIM",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "SPRL SVR INVEST",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "SA UTERON PHARMA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "SPRL MAJOCEPI",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "SA UTERON PHARMA",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0892.121.272",
    "name_full": "ODYSSEA PHARMA"
  }
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen24421
Primary activity highlighted.
Names & trade names
Legal nameFR ODYSSEA PHARMA
Registered office
Rue du Travail 16
4460 Grâce-Hollogne, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 26 of 148 with filed accounts
ASTEL MEDICA BE 0472.890.044 · Tinlot
GRAFTYS BE 0676.661.805 · Liège
Hyloris Developments BE 0542.737.368 · Liège
Hyloris Therapeutics BE 1025.029.385 · Liège
LONZA VERVIERS BE 0463.156.786 · Verviers
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative